Maria Donniacuo, Antonella De Angelis, Concetta Rafaniello, Eleonora Cianflone, Pasquale Paolisso, Daniele Torella, Gerolamo Sibilio, Giuseppe Paolisso, Giuseppe Castaldo, Konrad Urbanek, Francesco Rossi, Liberato Berrino, Donato Cappetta
Almost 20% of COVID-19 patients have a history of atrial fibrillation (AF), but also a new-onset AF represents a frequent complication in COVID-19. Clinical evidence demonstrates that COVID-19, by promoting the evolution of a prothrombotic state, increases the susceptibility to arrhythmic events during the infective stages and presumably during post-recovery. AF itself is the most frequent form of arrhythmia and is associated with substantial morbidity and mortality. One of the molecular factors involved in COVID-19-related AF episodes is the angiotensin-converting enzyme (ACE) 2 availability...
2023: Frontiers in Cardiovascular Medicine